RemedyAtlas
Back

Strontium

Its role in treating postmenopausal osteoporosis and as a radiopharmaceutical for bone metastasis pain management.

supplement
Human trial evidenceNeeds more research

Strontium is a mineral used in bone health research, specifically for osteoporosis and bone metastases. It is studied for its ability to influence bone formation markers and manage pain in late-stage bone cancers.

Last reviewed June 13, 2026 · AI-assisted, human-reviewed
Strontium is a chemical element that occurs naturally and is found in various forms, including dietary supplements and pharmaceutical compounds. In a medical context, strontium ranelate has been utilized in the management of postmenopausal osteoporosis due to its dual effect on bone metabolism. Additionally, specific isotopes such as Strontium-89 chloride act as radiopharmaceutical agents, primarily studied for their application in managing bone pain associated with metastatic cancer, such as thyroid cancer metastases. Research, including a phase IV clinical trial, has compared its effects on bone formation markers against other treatments like parathyroid hormone (PTH 1-84). While it has historically been a significant option for bone health, its use is often subject to strict regulatory oversight and clinical guidelines due to potential safety considerations and the specialized nature of radiopharmaceutical administration.

Quick answer

What it is: Strontium is a chemical element that occurs naturally and is found in various forms, including dietary supplements and pharmaceutical compounds.

May support:Osteoporosis

Evidence Summary

Evidence from a Phase IV clinical trial (n=82) indicates that strontium ranelate significantly influences bone formation markers in postmenopausal women with primary osteoporosis. Further clinical trial data (n=20) suggests that Strontium-89 chloride may be effective for patients with differentiated thyroid cancer experiencing bone metastases. Guidelines from ACR-ASTRO also support the use of strontium-based radiopharmaceutical sources when administered by licensed physicians under specific safety protocols.

Last reviewed · Jun 2026

Have you tried Strontium?

Vote in 5 seconds. Add details if you want.

Your experience for Osteoporosis:

Commonly Combined With

Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.

Community signal breakdown

Where this remedy is being discussed across the web and community.

See Community Mentions

People Like Me insights

As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.

Community Discussions

What people say about Strontium

Search on Reddit →

Latest News

Latest news on Strontium

More on Google News →

Health Videos

Health videos on Strontium

More on YouTube

Why It Works

Strontium is believed to exert a dual effect on bone by increasing bone formation through osteoblast activity and decreasing bone resorption by inhibiting osteoclasts.

How it works in more detail

Strontium compounds, particularly strontium ranelate, are thought to uncouple the bone remodeling process. It promotes the differentiation of osteoblast precursors and stimulates collagen synthesis, which may lead to increased bone formation markers. Simultaneously, it may reduce the differentiation and activity of osteoclasts, the cells responsible for bone breakdown. In the form of Strontium-89, the substance acts as a calcium analog that targets areas of high bone turnover, delivering localized beta radiation to treat painful bone metastases.

How to use

Always consult a qualified clinician.

Editorial guidance

Suggested dosage
Dosage is strictly determined by clinical protocols and varies significantly between the form used (e.g., strontium ranelate vs. Strontium-89 chloride). It should only be administered under professional medical guidance.
Research dosage range
In clinical settings investigating osteoporosis, specific pharmaceutical dosages are used, while Strontium-89 is dosed based on radioactive activity (mCi or MBq) proportional to patient weight or surface area.
Typical forms
capsule, powder

Community tips

No community tips yet — be the first to share what worked for you.

Suggested dosage

Dosage is strictly determined by clinical protocols and varies significantly between the form used (e.g., strontium ranelate vs. Strontium-89 chloride). It should only be administered under professional medical guidance.

General guidance — discuss specifics with a clinician.

Safety

Safety warnings

The use of unsealed radiopharmaceutical sources like Strontium-89 requires adherence to strict safety guidelines (ACR-ASTRO) to maintain safe conditions and prevent unnecessary radiation exposure. Medical supervision is mandatory for pharmaceutical-grade strontium due to its systemic impact on bone metabolism.

General guidance — discuss specifics with a clinician.

Evidence ecosystem

Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.

Overall grade

Evidence from a Phase IV clinical trial (n=82) indicates that strontium ranelate significantly influences bone formation markers in postmenopausal women with primary osteoporosis. Further clinical trial data (n=20) suggests that Strontium-89 chloride may be effective for patients with differentiated thyroid cancer experiencing bone metastases. Guidelines from ACR-ASTRO also support the use of strontium-based radiopharmaceutical sources when administered by licensed physicians under specific safety protocols.

Filter by source type

Clinical Guidelines(1)

Recommendations from medical societies (NICE, AHA, ADA, ACG, Endocrine Society…).

High Quality

  • ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.

    Henkin RE, Del Rowe JD, Grigsby PW, Hartford AC, Jadvar H, Macklis RM · Clinical nuclear medicine · 2011

    This guideline is intended to guide appropriately trained and licensed physicians performing therapy with unsealed radiopharmaceutical sources. Adherence to this guideline should help to maximize the efficacious use of these procedures, maintain safe conditions, and ensure compliance with applicable regulations. The topics dealt with in this guideline include indications for the use of iodine-131, both for the treatment of hyperthyroidism and thyroid carcinoma. In addition, indications for other less common procedures include those for the use of phosphorous-32 in its liquid and colloidal forms, strontium-89, samarium-153, and the use of Y-90 antibodies.

    Clinical GuidelinePubMed (Practice Guideline)Very High Quality

Observational Studies(1)

Cohort, case-control, and cross-sectional human studies.

Moderate Quality

  • Systemic drugs with impact on osteoarthritis.

    Apostu D, Lucaciu O, Mester A, Oltean-Dan D, Baciut M, Baciut G · Drug metabolism reviews · 2019

    Articular cartilage has a complex structure and metabolism which allow for a proper movement within joints. Nevertheless, several systemically administered pharmacological agents have been proved to improve the anabolic response in the case of cartilage lesions. Alendronate, glucosamine, chondroitin sulfate, hyaluronic acid, collagen hydrolysate, vitamin C, vitamin D, aspirin and strontium ranelate have shown positive results in clinical trials. On the other hand, calcitonin, risedronate, doxycycline, and celecoxib did not slow the progression of cartilage lesions in clinical trials. Other systemic drugs or supplements such as teriparatide, leptin, zoledronic acid, bevacizumab, atorvastatin, omega-3 fatty acid, naringin, MSM, selenium, zinc, magnesium, resveratrol, donepezil, naproxen, etodolac, ursodeoxycholic acid (UDCA), lithium chloride, and rebamipide showed positive results in in vitro and animal studies but clinical trials are needed to confirm the positive impact on cartil

    Observational StudyPubMedLow Quality

Clinical Trial Registries(2)

Registered ongoing or completed trials (ClinicalTrials.gov).

Moderate Quality

Limitations: Clinical trials for specific applications like thyroid cancer metastases often involve small sample sizes (n=20), which may limit the generalizability of the findings. Research comparing strontium ranelate to parathyroid hormone (PTH) is often limited to specific biomarkers rather than long-term fracture outcomes in every instance.

This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.

Tried Strontium?

Help others see what actually works.